PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.440.14 (-2.51%)
5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.93%
Revenue growth at 75-90% of UPM.HE's 1.18%. Bill Ackman would push for innovation or market expansion to catch up.
4.57%
Gross profit growth under 50% of UPM.HE's 22.47%. Michael Burry would be concerned about a severe competitive disadvantage.
29.21%
EBIT growth 50-75% of UPM.HE's 40.89%. Martin Whitman would suspect suboptimal resource allocation.
29.21%
Operating income growth at 50-75% of UPM.HE's 40.89%. Martin Whitman would doubt the firm’s ability to compete efficiently.
12.29%
Net income growth under 50% of UPM.HE's 39.51%. Michael Burry would suspect the firm is falling well behind a key competitor.
22.22%
EPS growth at 50-75% of UPM.HE's 42.11%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
22.22%
Diluted EPS growth at 50-75% of UPM.HE's 42.11%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-8.13%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-8.13%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
81.94%
Similar OCF growth to UPM.HE's 80.67%. Walter Schloss would assume comparable operations or industry factors.
141.37%
FCF growth above 1.5x UPM.HE's 88.84%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-31.36%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-37.05%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-6.92%
Negative 3Y CAGR while UPM.HE stands at 2.96%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-10.70%
Negative 10Y OCF/share CAGR while UPM.HE stands at 165.41%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
38.92%
5Y OCF/share CAGR at 75-90% of UPM.HE's 50.14%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
31.48%
3Y OCF/share CAGR at 50-75% of UPM.HE's 61.58%. Martin Whitman would suspect weaker recent execution or product competitiveness.
145.83%
Similar net income/share CAGR to UPM.HE's 135.84%. Walter Schloss would see parallel tailwinds or expansions for both firms.
243.75%
Below 50% of UPM.HE's 754.09%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
88.80%
3Y net income/share CAGR above 1.5x UPM.HE's 56.73%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-5.23%
Negative 5Y equity/share growth while UPM.HE is at 10.39%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
30.35%
3Y equity/share CAGR above 1.5x UPM.HE's 8.96%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.94%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-3.32%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.14%
Asset growth above 1.5x UPM.HE's 1.04%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
11.35%
BV/share growth above 1.5x UPM.HE's 3.15%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
1.70%
We have some new debt while UPM.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-8.90%
We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.